CAPR
Capricor Therapeutics, Inc.Company with tickers: CAPR
CIK
1133869
CUSIP
14070B309
Shares Outstanding
57,911,893
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $36,772,853 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $27,376,912 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-36,772,853 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-33,941,345 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.59 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.59 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |